Viewing Study NCT00737932


Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2026-01-02 @ 2:08 PM
Study NCT ID: NCT00737932
Status: COMPLETED
Last Update Posted: 2015-03-20
First Post: 2008-08-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Laquinimod Phase IIa Study in Active Crohn's Disease
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module